Literature DB >> 8423350

Methods for assessing complement activation in the clinical immunology laboratory.

J M Porcel1, M Peakman, G Senaldi, D Vergani.   

Abstract

Complement activation is a key component of the pathogenesis of immune-mediated tissue damage in many diseases. Assessment of complement activation in current practice is largely based on the measurement of intact C3 and C4 or the determination of complement haemolytic function. These parameters reflect activation only indirectly, are insensitive and open to influence by factors other than complement conversion. New approaches to evaluate complement activation directly using sensitive techniques have been developed, and several could be adopted easily in most laboratories. These concentrate on the detection of activation fragments, neoantigens or complexes that only arise as a direct result of complement activation. The wide application of these techniques in research and clinical practice would enhance our understanding of the pathogenesis of a range of inflammatory and infectious diseases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423350     DOI: 10.1016/0022-1759(93)90063-d

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  [Laboratory diagnostics of systemic autoimmune diseases. Part 1. Collagenoses].

Authors:  K Hartung; H-P Seelig
Journal:  Z Rheumatol       Date:  2006-12       Impact factor: 1.372

2.  Determination of complement-mediated killing of bacteria by viability staining and bioluminescence.

Authors:  M Virta; S Lineri; P Kankaanpää; M Karp; K Peltonen; J Nuutila; E M Lilius
Journal:  Appl Environ Microbiol       Date:  1998-02       Impact factor: 4.792

Review 3.  Clinical utility of complement assessment.

Authors:  A E Ahmed; J B Peter
Journal:  Clin Diagn Lab Immunol       Date:  1995-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.